The role of minor histocompatibility alloantigens in penetrating keratoplasty
- PMID: 12494683
- DOI: 10.1159/000067655
The role of minor histocompatibility alloantigens in penetrating keratoplasty
Abstract
Background/aims: To review the experimental evidence that implicates minor histocompatibility (H) antigens in the vulnerability of orthotopic corneal transplants to rejection, and to speculate on the possible role of minor H antigens in penetrating keratoplasty in humans.
Methods: Orthotopic corneal transplantations have been conducted in numerous inbred strains of mice and rats, and the fate of these grafts, as well as the immune responses mounted by recipients, have been examined in vivo and in vitro.
Results: Minor H antigens have been found to be more important barriers to the success of orthotopic corneal transplants in rodents than have grafts disparate at the major histocompatibility complex (MHC). The reasons for this reversal of the immunogenetic rules of transplantation reflect unique features of the cornea with respect to (a) expression of MHC-encoded molecules, (b) content of class II MHC-bearing antigen presenting cells, (c) vulnerability to rejection by direct alloreactive T cells, and (d) existence of ocular immune privilege.
Conclusion: Since minor H antigens are the major barriers to acceptance of orthotopic corneal allografts in rodents, minor H antigens should be considered as important targets of rejection in failed penetrating keratoplasty in humans.
Similar articles
-
Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.Invest Ophthalmol Vis Sci. 1997 May;38(6):1130-8. Invest Ophthalmol Vis Sci. 1997. PMID: 9152232
-
MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes.Cornea. 2005 Apr;24(3):312-8. doi: 10.1097/01.ico.0000138852.26332.1c. Cornea. 2005. PMID: 15778605
-
An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.Transplantation. 2003 Apr 27;75(8):1368-74. doi: 10.1097/01.TP.0000063708.26443.3B. Transplantation. 2003. PMID: 12717232
-
Immune mechanisms of corneal allograft rejection.Curr Eye Res. 2007 Dec;32(12):1005-16. doi: 10.1080/02713680701767884. Curr Eye Res. 2007. PMID: 18085464 Review.
-
The immune privilege of corneal grafts.J Leukoc Biol. 2003 Aug;74(2):167-71. doi: 10.1189/jlb.1102543. J Leukoc Biol. 2003. PMID: 12885932 Review.
Cited by
-
Immunology and Donor-Specific Antibodies in Corneal Transplantation.Arch Immunol Ther Exp (Warsz). 2021 Nov 6;69(1):32. doi: 10.1007/s00005-021-00636-3. Arch Immunol Ther Exp (Warsz). 2021. PMID: 34741683 Free PMC article. Review.
-
Alloimmunity and Tolerance in Corneal Transplantation.J Immunol. 2016 May 15;196(10):3983-91. doi: 10.4049/jimmunol.1600251. J Immunol. 2016. PMID: 27183635 Free PMC article. Review.
-
Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.Mol Vis. 2011;17:2148-56. Epub 2011 Aug 11. Mol Vis. 2011. PMID: 21850190 Free PMC article.
-
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy.Int J Tryptophan Res. 2016 Oct 12;9:67-77. doi: 10.4137/IJTR.S38355. eCollection 2016. Int J Tryptophan Res. 2016. PMID: 27773992 Free PMC article. Review.
-
Immunopathogenesis of corneal graft rejection.Indian J Ophthalmol. 2023 May;71(5):1733-1738. doi: 10.4103/IJO.IJO_2866_22. Indian J Ophthalmol. 2023. PMID: 37203024 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials